Related Experiment Video
Updated: Apr 29, 2026
05:44
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
Published on: November 5, 2020
4.5K
Serum CA19-9 in patients with solid pancreatic mass
Mahmud Baghbanian1, Ali Baghbanian2, Hasan Salmanroghani1
1Deprtment of Gasteroenterology, Shahid Sadoghi University of Medical Sciences, Yazd, Iran.
Gastroenterology and Hepatology From Bed to Bench
|May 17, 2014
Summary
Serum CA 19-9 has limited value in diagnosing pancreatic cancer. This tumor marker showed low sensitivity and specificity, and its results should be interpreted alongside clinical and imaging data.
Area of Science:
- Oncology
- Gastroenterology
- Biomarkers
Background:
- CA 19-9 is a widely used tumor marker for pancreatic cancer.
- Its utility in diagnosis, prognosis, and treatment monitoring is recognized.
Purpose of the Study:
- To evaluate the efficacy of serum CA 19-9 in differentiating pancreatic solid masses.
- To assess its diagnostic performance for pancreatic adenocarcinoma.
Main Methods:
- A prospective, descriptive, case series study.
- 159 patients with pancreatic solid masses were analyzed.
- Serum CA 19-9 levels were correlated with histopathology.
Main Results:
- Adenocarcinoma was diagnosed in 82% of patients.
- The mean CA 19-9 level was significantly higher in malignant cases compared to benign lesions.
- At a cutoff of 58 U/ML, CA 19-9 showed 85% sensitivity and 67% specificity for adenocarcinoma.
Conclusions:
- Serum CA 19-9 has limited sensitivity and specificity for diagnosing pancreatic cancer.
- It cannot be used as a definitive diagnostic test alone.
- Clinical and imaging findings are crucial for interpreting CA 19-9 results in pancreatic masses.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
563
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
563
01:30Serum Laboratory Studies, Stool Test, Breath Test
1.2K
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
1.2K